|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 10.24 USD | -0.63% |
|
+2.56% | +52.31% |
| Mar. 10 | Novavax, Inc. Presents at Leerink Global Healthcare Conference 2026, Mar-10-2026 03:40 PM | |
| Mar. 03 | Novavax, Inc. Presents at TD Cowen 46th Annual Health Care Conference, Mar-03-2026 02:30 PM |
Company Valuation: Novavax, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 10,817 | 883.9 | 570.2 | 1,288 | 1,092 | 1,668 | - | - |
| Change | - | -91.83% | -35.49% | 125.87% | -15.21% | 52.72% | - | - |
| Enterprise Value (EV) 1 | 9,756 | -228.1 | 169.7 | 534.5 | 1,092 | 1,887 | 1,971 | 1,668 |
| Change | - | -102.34% | 174.39% | 214.93% | 104.32% | 72.77% | 4.46% | -15.38% |
| P/E ratio | -6.1x | -1.22x | -0.89x | -6.54x | 2.6x | -28.7x | -31.5x | 44.8x |
| PBR | -30.9x | -1.38x | -0.93x | -2.07x | - | -2.91x | -2.79x | - |
| PEG | - | 0x | 0x | 0.1x | -0x | 0x | 3.58x | -0x |
| Capitalization / Revenue | 9.44x | 0.45x | 0.58x | 1.89x | 0.97x | 4.35x | 6.8x | 4.92x |
| EV / Revenue | 8.51x | -0.12x | 0.17x | 0.78x | 0.97x | 4.92x | 8.03x | 4.92x |
| EV / EBITDA | - | 0.37x | -0.32x | -2.67x | - | -78x | -40x | -36.8x |
| EV / EBIT | -5.78x | 0.35x | -0.3x | -2.15x | 1.98x | -35.5x | -42.6x | 29.1x |
| EV / FCF | 36.8x | 0.45x | -0.22x | -5.33x | - | 16x | -19.9x | 6.15x |
| FCF Yield | 2.72% | 221% | -452% | -18.8% | - | 6.25% | -5.02% | 16.3% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | -23.44 | -8.42 | -5.41 | -1.23 | 2.58 | -0.3563 | -0.3249 | 0.2287 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 1,146 | 1,982 | 983.7 | 682.2 | 1,123 | 383.5 | 245.4 | 338.9 |
| EBITDA 1 | - | -615.7 | -525.3 | -200.4 | - | -24.18 | -49.22 | -45.37 |
| EBIT 1 | -1,687 | -644.7 | -566.5 | -248.9 | 550.6 | -53.1 | -46.24 | 57.33 |
| Net income 1 | -1,744 | -657.9 | -545.1 | -187.5 | 440.3 | -57.9 | -54.43 | 39.34 |
| Net Debt 1 | -1,061 | -1,112 | -400.5 | -753.4 | - | 219 | 303.2 | - |
| Reference price 2 | 143.07 | 10.28 | 4.80 | 8.04 | 6.72 | 10.24 | 10.24 | 10.24 |
| Nbr of stocks (in thousands) | 75,608 | 85,979 | 118,790 | 160,185 | 162,499 | 162,936 | - | - |
| Announcement Date | 2/28/22 | 2/28/23 | 2/28/24 | 2/27/25 | 2/26/26 | - | - | - |
1USD in Million2USD
Estimates
P/E ratio, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -28.73x | 4.92x | -78.02x | -.--% | 1.67B | |
| 33.07x | 4.92x | 16.5x | 1.02% | 42.78B | |
| 51.96x | 4.42x | 29.75x | -.--% | 31.5B | |
| 54.26x | 11.14x | 30.96x | 0.35% | 29.99B | |
| 19.97x | 2.36x | 10.18x | -.--% | 27.65B | |
| -12.38x | 320.84x | -10.44x | -.--% | 18.8B | |
| 43.12x | 8.22x | 25.82x | -.--% | 13.87B | |
| 26.34x | 4.19x | 19.06x | -.--% | 12.78B | |
| 20.1x | 1.87x | 8.16x | 1.23% | 12.39B | |
| -17.61x | 13.71x | -19.11x | -.--% | 11.76B | |
| Average | 19.01x | 37.66x | 3.29x | 0.26% | 20.32B | |
| Weighted average by Cap. | 29.17x | 35.14x | 14.79x | 0.34% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Equities
- NVAX Stock
- Valuation Novavax, Inc.
Select your edition
All financial news and data tailored to specific country editions
